Clinical Scorecard: Comparison of Octenidine and Sterile Water for Cleansing to Address Late-Onset Sepsis in NICU Neonates: A Randomized Clinical Trial
At a Glance
Category
Detail
Condition
Late-onset sepsis (LOS)
Key Mechanisms
Colonization of neonatal skin and mucous membranes with pathogenic microorganisms leading to bloodstream invasion.
Target Population
Neonates admitted to NICUs within 48 hours of birth.
Care Setting
Neonatal intensive care units (NICUs)
Key Highlights
LOS affects 0.6% to 14.2% of neonates in NICUs.
Octenidine shows faster bactericidal activity and longer residual effects compared to chlorhexidine.
The study evaluates the efficacy of octenidine versus sterile water in preventing LOS.
Guideline-Based Recommendations
Diagnosis
Diagnosis of LOS should be based on clinical and laboratory criteria.
Management
Daily cleansing with octenidine or sterile water as part of infection control measures.
Monitoring & Follow-up
Monitor for signs of infection and sepsis in neonates.
Risks
Consider risks associated with skin antisepsis in neonates, including potential adverse reactions.
Patient & Prescribing Data
Neonates of all gestational ages admitted to NICUs.
Octenidine wipes (0.1% concentration) used for cleansing; sterile water as control.
Clinical Best Practices
Implement standardized cleansing protocols in NICUs.
Ensure proper hand hygiene among healthcare workers to reduce pathogen transmission.
